Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing

Authors

• Matthew J Ziegler
• Craig Freyer
• Daniel Landsburg
• David Pegues
• Warren Bilker
• Rebecca Hirsh
• Colleen Kucharczuk
• Cheryl Gilmar
• Theresa Gorman
• Melissa Palmer
• Christina Harker
• Erin Lightheart
• Jennifer H Han

Publication/Presentation Date

11-1-2019

Abstract

We implemented a guideline for appropriate acid suppressant use in hematology-oncology patients. This intervention resulted in a sustained reduction in proton pump inhibitor (PPI) use without an increase in rates of gastrointestinal bleeding. Practice guidelines are effective in reducing PPI use, which is associated with risk of Clostridioides difficile infection.

Volume

40

Issue

11

First Page

1294

Last Page

1296

ISSN

1559-6834

Published In/Presented At

Ziegler MJ, Freyer C, Landsburg D, Pegues D, Bilker W, Hirsh R, Kucharczuk C, Gilmar C, Gorman T, Palmer M, Harker C, Lightheart E, Han JH. Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing Clostridioides difficile risk. Infect Control Hosp Epidemiol. 2019 Nov;40(11):1294-1296. doi: 10.1017/ice.2019.238. Epub 2019 Aug 30. PMID: 31466535; PMCID: PMC6893867.

PubMedID

31466535

Department(s)

Hematology-Medical Oncology Division

Document Type

Article